Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,203 | 99,427 | 125,061 | 94,952 | 111,576 |
| Marketable Securities | 29,213 | 38,812 | 41,280 | 36,002 | 45,683 |
| Receivables | 19,339 | 19,106 | 19,256 | 8,376 | 15,771 |
| Inventories | 674 | 299 | 222 | 171 | 318 |
| Other current assets | 0 | 0 | 0 | 37,948 | 0 |
| TOTAL | $159,518 | $171,524 | $200,157 | $183,181 | $184,087 |
| Non-Current Assets | |||||
| PPE Net | 14,642 | 14,163 | 12,278 | 7,116 | 8,221 |
| Investments And Advances | 0 | 565 | 1,272 | 1,390 | 923 |
| Intangibles | 32,580 | 32,259 | 33,045 | 883 | 34,628 |
| Other Non-Current Assets | 18,179 | 18,355 | 18,323 | 53,380 | 17,232 |
| TOTAL | $65,401 | $65,342 | $64,918 | $62,769 | $61,004 |
| Total Assets | $224,919 | $236,866 | $265,075 | $245,950 | $245,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38,205 | 39,436 | 45,838 | 28,618 | 33,273 |
| Accrued Expenses | 11,974 | 10,652 | 10,713 | N/A | 11,343 |
| Other current liabilities | 730 | 847 | 9,434 | 29,592 | 10,176 |
| TOTAL | $70,775 | $62,158 | $79,326 | $71,438 | $68,428 |
| Non-Current Liabilities | |||||
| Long Term Debt | 64,546 | 73,456 | 73,444 | 39,212 | 40,734 |
| Deferred Revenues | 155 | 650 | 690 | N/A | 680 |
| Other Non-Current Liabilities | 16,910 | 19,092 | 21,959 | 30,403 | 23,855 |
| TOTAL | $69,507 | $78,443 | $78,203 | $54,010 | $55,398 |
| Total Liabilities | $140,282 | $140,601 | $157,529 | $125,448 | $123,826 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,781 | 3,625 | 3,529 | 3,425 | 3,379 |
| Common Shares | 551 | 830 | 541 | 551 | 404 |
| Retained earnings | -371,394 | -354,756 | -333,145 | -312,127 | -301,714 |
| Other shareholders' equity | 46,864 | 52,332 | 65,895 | 67,929 | 84,321 |
| TOTAL | $84,637 | $96,265 | $107,546 | $120,502 | $121,265 |
| Total Liabilities And Equity | $224,919 | $236,866 | $265,075 | $245,950 | $245,091 |